The paper entitled " Generative Recurrent Network For Design SARS-CoV-2 Main Protease Inhibitor" proposed a system to generate a potential SARS-CoV-2 main protease Inhibitor. It generates SARS-CoV-2 inhibitor by using a method similar to the process found in evolution algorithms to optimize a deep generative model in developing drugs with high-affinity scores toward SARS-CoV-2,
The paper is now published, and can be viewed here,